Professional Documents
Culture Documents
Husserlian Self-Awareness and Selective Serotonin Reuptake Inhibitors
Husserlian Self-Awareness and Selective Serotonin Reuptake Inhibitors
Inhibitors
Peter Hadreas
Philosophy, Psychiatry, & Psychology, Volume 17, Number 1,
March 2010, pp. 43-51 (Article)
Published by The Johns Hopkins University Press
DOI: 10.1353/ppp.0.0279
contrast in moods urges the adoption of an adequate model of self-awareness. The experiences
of those who respond poorly to SSRIs are also
relevant in that their own first-person descriptions of before and after SSRI use presume a
model of self-awareness. Inadequate are notions
of self-awareness proffered by psychologists and
philosophers of both of empiricist and rationalist
camps. They convey unsuitable and misleading
paradigms2 for explaining the experiences of both
those affected positively and negatively by SSRIs.
Instead, a suitable model of self-awareness is
offered by founding phenomenologist, Edmund
Husserl, particularly as developed in his middle
and late writings.
First, Ill present some preliminary remarks
regarding current uncertainties both as to how
SSRIs work and whom they help.
The U.S. Food and Drug Administration approved fluoxetine in 1987. During the salad days
of SSRIs usage, unbridled enthusiasm came from
various quarters as to the efficacy of SSRIs for
treating a broad variety of psychological ills. Peter
Kramer in 1993s Listening to Prozac was a bellwether of the times. Kramer announced that SSRIs
were successfully prescribed to treat not only clinically codifiable mental illnesses, but also personality traits such as shyness and diffidence. In patient
Husserl on Self-Awareness
How does the Husserlian concept of selfawareness help in understanding the testimony
of SSRIs good and bad responders? First a note
as to the sources of Husserls reflection on selfawareness. As Husserl scholar Dan Zahavi rightly
notes, Husserls views on self-awareness are not
adequately contained in the writings published
in his lifetime but in the posthumously published
volumes of Husserliana as well as in manuscripts
still left unpublished (Zahavi 1999, 50). Even so
Husserls views on self-awareness have given rise
to intense debates and schools of interpretation.
How so? Zahavis response is worth quoting. He
states that, One answer is that self-awareness is
not simply a but rather the fundamental problem
of phenomenology (Zahavi 1999, 50).
In fact Husserl investigates and offers innovative explications regarding the notion of selfconsciousness as offered by both the empiricist and
rationalist camps. Husserl has plenty to say about
how the empirical Ego of the empiricists3 arises
as well as how the pure Ego of the rationalists is
intuited.4 Zahavis saying that self-awareness .
. . is the fundamental problem of phenomenology is warranted. We should also add that it is
fundamental inasmuch as Husserl offers innovative work on both the empiricist and rationalist
approach, as well as on a third approach, which
would ground the two traditional camps. Husserls most significant contribution to the topic of
self-awareness likely lies in his developing a prereflective self, which grounds, and is a necessary
condition for, both the empiricist and rationalist
notions of self.
Husserl, like William James, came to found consciousness on a subtle level of strivings, urges, and
endeavors. James understood these pre-conscious
tendencies as fringe promptings of furtherance
or forbearance (James 1890/1948, Feelings of
Tendency, 16187). Husserl instead describes
these pre-consciousness tendencies as striving
(Streben).
The ordinary experience of breathing provides
an example for observing pre-objective strivings.
The impulse to breathe is not so much a desire, as
a tendency, an urge, a prompting. It is not directed
Notes
1. Other SSRIs currently prescribed in the United
States besides fluoxetine hydrochloride (Prozac) are
sertraline (Zoloft), paroxetine (Paxil), fluvoxamine
maleate (Luvox), and citalopram (Celexa). We follow
the current tendency to lump SSRIs into the same class
designation. However, it should be noted that it has been
demonstrated that these drugs, although all curtailing
serotonin reuptake, differ in their effects upon other
References
Aristotle. 1984. Nicomachean ethics. In The complete
works of Aristotle, volume 2, ed. J. Barnes, 1729
1867. Princeton, NJ: Princeton University Press.
Barondes, S. H. 2003. Better than Prozac. Oxford:
Oxford University Press.
Begley, S. 2004. Why depression looks different in a kids
brain. The Wall Street Journal October 15.
Bonjour, L. 1998. In defense of pure reason. Cambridge:
Cambridge University Press.
Carruthers, P. 1992. Human knowledge and human
nature. Oxford: Oxford University Press.
Chomsky, N. 1975. Recent contributions to the theory
of innate ideas. Reprinted in S. Stitch, ed., Innate
ideas. Berkeley: California University Press.
Cottingham, J. 1984. Rationalism. London: Paladin
Books.
Grunberger, J., and B. Saletu. 1980. Determination
of pharmacodynamics of psychotropic drugs by
psychometric analysis. Progress in Neuropsychopharmacology 4:41734.
Locke, J. 1952. An essay concerning human understanding. In Vol. XXXV Great books of the western world.
Chicago: Encyclopedia Britannica, Inc.
Mensch, J. R. 1998. InstinctA Husserlian account.
Husserl Studies 14:21937.
Merleau-Ponty, M. 1989. Phenomenology of perception. London: Routledge.
Rescher, N. 1991. G. W. Leibnizs Monadology. Pittsburgh: University of Pittsburgh Press.
Russell, B. 1959. The problems of philosophy. Oxford:
Oxford University Press.
Saletu, B., Grunberger, J., and L. Linzmayer. 1986. On
the central effects of serotonin reuptake inhibitors:
Quantitative EEG and psychometric studies with
Sertraline and Imipramine. Journal of Neural Transmission 67:24166.
Slater, L. 1998. Prozac diary. New York: Random
House.
Tollefson, G. D., and J. F. Rosenbaum. 2001. Selective
serotonin reuptake inhibitors. In Essentials of clinical
psychopharmacology, ed. A. F. Schatzberg, and C.
B. Nemeroff, 16182. Washington, DC: American
Psychiatric Publishing, Inc.
Warrington, S. J., Dana-Haeri, J., and A. J. Sinclair.
1989. Cardiovascular and psychomotor effects of
repeated doses of Paroxetine: A comparison with
Amitriptyline and placebo in healthy men. Acta
Psychiatrica Scandinavia 80(Suppl 350):424.
Wittgenstein, L. 1965. The blue and brown books. New
York: Harper & Row.
Wurtzel, E. 1995. Prozac nation. New York: Riverhead
Books.
Zahavi, D. 1999. Self-Awareness and alterity: A phenomenological investigation. Evanston, IL: Northwestern University Press.